
Barinthus Biotherapeutics Investor Relations Material
Latest events

Status Update
Barinthus Biotherapeutics

Q1 2025
7 May, 2025

Corporate Presentation
6 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Barinthus Biotherapeutics plc
Access all reports
Barinthus Biotherapeutics plc is a biotechnology company focused on the development of novel immunotherapies for infectious diseases and cancer. The company specializes in T-cell activating therapeutics and next-generation vaccine platforms designed to enhance immune response. The company is headquartered in London, United Kingdom, and its shares are listed on the NASDAQ.
Key slides for Barinthus Biotherapeutics plc


Corporate Presentation
Barinthus Biotherapeutics plc


Corporate Presentation
Barinthus Biotherapeutics plc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
BRNS
Country
🇺🇸 United States